Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Alligator Bioscience

0.02 SEK0.00 %9.9, 17.29
Less than 1K followers

ATORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
0.00 %
-8.00 %
-82.08 %
-81.96 %
-89.51 %
-97.43 %
-99.64 %
-99.94 %
-99.99 %

Alligator Bioscience is a research-based biotechnology company. The company uses a patented technology to develop biological drug candidates in inflammation and cancer, and is active in the earlier part of the drug development chain. Alligator Bioscience has a global technology platform and is active in the protein pharmaceutical segment. The company was founded in 2001 and is headquartered in Lund.

Read more
Market cap
165.82M SEK
Turnover
390.74K SEK
Revenue
510K
EBIT %
-20,750.2 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
22.10
2026

Interim report Q3'26

11.2
2027

Annual report '26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release31.08.2026, 14.15

Alligator Bioscience publishes prospectus in connection with rights issue

Alligator Bioscience
Press release28.08.2026, 11.15

Redeye: Alligator Bioscience (Q2 2026 Review): The HLX22 waiting game

Alligator Bioscience
Regulatory press release26.08.2026, 11.30

Bulletin from the extraordinary general meeting in Alligator Bioscience AB

Alligator Bioscience

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release26.08.2026, 08.00

Alligator Bioscience AB reports financial results for the period 1 January – 30 June 2026 and provides a business update

Alligator Bioscience
Press release20.08.2026, 08.45

Invitation to Alligator Bioscience’s earnings call on 26 August 2026

Alligator Bioscience
Regulatory press release23.07.2026, 08.50

Notice of extraordinary general meeting in Alligator Bioscience AB

Alligator Bioscience
Regulatory press release23.07.2026, 08.17

Alligator discontinues independent development of mitazalimab for a strategic refocus on the HLX22 project, announces a rights issue of units of approximately SEK 125.6 million and raises bridge loans

Alligator Bioscience
Press release02.07.2026, 10.30

Alligator announces first patient dosed in investigator-initiated study of intratumoral mitazalimab in early-stage breast cancer

Alligator Bioscience
Press release08.06.2026, 08.45

Alligator Bioscience comments on Henlius update on global phase 3 trial with HLX22

Alligator Bioscience
Press release22.05.2026, 08.45

Alligator Bioscience comments on Henlius update on long-term follow-up data for HLX22

Alligator Bioscience
Press release08.05.2026, 10.11

Redeye: Alligator Bioscience (Q1 2026 Review): Pragmatic Path to Phase III

Alligator Bioscience
Regulatory press release06.05.2026, 11.15

Bulletin from the annual general meeting in Alligator Bioscience AB on 6 May 2026

Alligator Bioscience
Regulatory press release05.05.2026, 08.00

Alligator Bioscience AB reports financial results for the period 1 January – 31 March 2026 and provides a business update

Alligator Bioscience
Press release28.04.2026, 08.30

Invitation to Alligator Bioscience’s earnings call on 5 May 2026

Alligator Bioscience
Press release23.04.2026, 10.00

Alligator Bioscience comments on Henlius presentation of HLX49 preclinical data at AACR 2026

Alligator Bioscience
Press release20.04.2026, 08.45

New data from investigator‑initiated study evaluating Alligator Bioscience’s mitazalimab to be presented at AACR Annual Meeting 2026

Alligator Bioscience
Press release10.04.2026, 14.15

Alligator Bioscience provides an update on mitazalimab

Alligator Bioscience
Regulatory press release31.03.2026, 15.00

Change in number of shares and votes in Alligator Bioscience AB

Alligator Bioscience
Regulatory press release30.03.2026, 08.45

Notice of annual general meeting in Alligator Bioscience AB

Alligator Bioscience
Regulatory press release27.03.2026, 11.30

The Nomination Committee’s proposals regarding the Board of Directors for the Annual General Meeting in Alligator Bioscience AB (publ)

Alligator Bioscience